Cirina Inc., a South San Francisco, CA-based developer of blood-plasma tests for early detection of deadly diseases, undisclosed the completion of a $12m Series A financing.
The round, whose closing occourred in 2015, was led by Min Cui, PhD, Founding Partner and Managing Director of Decheng Capital.
Co-founded in 2014 by plasma nucleic acid scientist Dennis Lo, DM, DPhil and led by newly appointed CEO Maneesh Jain, PhD, Cirina is advancing products that aim to enable clinicians to diagnose various forms of cancer and other deadly diseases at their earliest stages, empowering people to take action when curative treatment is still viable.
Dennis Lo was the first scientist to discover the presence of fetal DNA in a pregnant mother’s blood-plasma. He has been recognized with several awards for his numerous discoveries and lifetime of contributions to the field.
CEO Maneesh Jain is a Caltech and Stanford-trained entrepreneur with early/founding roles in genomics companies like ParAllele, Auriphex, and Ion Torrent, followed by senior executive roles, post-merger and acquisition, at Affymetrix, Illumina, and Life Technologies.
He most recently served as President and COO of Butterfly Network, a medical imaging company, where he helped raise more than $100M in financing.